| Keith R Birchard, MD | |
|
1900 Cooks Hill Rd, Centralia, WA 98531-9073 | |
| (360) 736-2886 | |
| (360) 736-3136 |
| Full Name | Keith R Birchard |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 25 Years |
| Location | 1900 Cooks Hill Rd, Centralia, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164534350 | NPI | - | NPPES |
| 8396467 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD00041707 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Centralia Hospital | Centralia, WA | Hospital |
| Arbor Health Morton Hospital | Morton, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Orthopaedic Center Inc Ps | 5496643165 | 8 |
News Archive
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
Nancy Lindborg, USAID's assistant administrator for the Bureau for Democracy, Conflict and Humanitarian Assistance, writes in this post in USAID's "IMPACTblog" that the U.S. "continues to call on all parties involved to allow unfettered humanitarian access to Somalis in need."
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
Researchers in the University of Georgia's Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd. (TASE: BIOV) today jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer.
› Verified 4 days ago
| Entity Name | Washington Orthopaedic Center Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689787103 PECOS PAC ID: 5496643165 Enrollment ID: O20040308000977 |
News Archive
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
Nancy Lindborg, USAID's assistant administrator for the Bureau for Democracy, Conflict and Humanitarian Assistance, writes in this post in USAID's "IMPACTblog" that the U.S. "continues to call on all parties involved to allow unfettered humanitarian access to Somalis in need."
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
Researchers in the University of Georgia's Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd. (TASE: BIOV) today jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith R Birchard, MD 1900 Cooks Hill Rd, Centralia, WA 98531-9073 Ph: (360) 736-2886 | Keith R Birchard, MD 1900 Cooks Hill Rd, Centralia, WA 98531-9073 Ph: (360) 736-2886 |
News Archive
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
Nancy Lindborg, USAID's assistant administrator for the Bureau for Democracy, Conflict and Humanitarian Assistance, writes in this post in USAID's "IMPACTblog" that the U.S. "continues to call on all parties involved to allow unfettered humanitarian access to Somalis in need."
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
Researchers in the University of Georgia's Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd. (TASE: BIOV) today jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer.
› Verified 4 days ago
Dr. Chad Bender, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-330-1897 | |
Keith V Anderson, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-736-2889 Fax: 360-736-3136 | |
Scott C Slattery, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-736-2899 Fax: 360-736-3136 | |
Christopher A Hawkins, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-330-1874 Fax: 610-973-1778 |